Lupin Ltd. News and Updates

Name: Latest research reports of Lupin Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Lupin Ltd.
Rating: 3
Author: Geojit BNP Paribas

Keep track of all breaking news on Lupin Ltd. from all sources in a single place.

Load latest

Lupin Ltd.

12 Sep 2023

1966.90

-3.09%

Lupin gains 1.3% on business transfer agreement with subsidiary

Moneycontrol

Under the business transfer agreement, the pharma major will move the two active pharmaceutical ingredients (APIs) manufacturing sites at Dabhasa and Visakhapatnam to the subsidiary.

Number of FII/FPI investors increased from 964 to 979 in Mar 2025 qtr.

Lupin Ltd.

07 Sep 2023

1966.90

-3.09%

Lupin Ltd partners with COPD, shares decline

Business Line

The shares were down by 0.27 per cent to Rs 1136.05 at 11.54 am on the BSE

Lupin Ltd. has an average target of 2329.44 from 9 brokers.

Lupin initiative to improve access to pulmonary disease medication in US

Business Line | 07 Sep 2023 1 more

Lupin Ltd.

30 Aug 2023

1966.90

-3.09%

Lupin gains on launching heart drug in Canada

Moneycontrol

Lupin Pharma Canada Ltd., a wholly-owned subsidiary of Lupin, launched Propranolol LA (long-acting) capsules of 60 mg, 80 mg, 120 mg and 160 mg, in Canada

Lupin Ltd. is trading below all available SMAs

Lupin Ltd.

29 Aug 2023

1966.90

-3.09%

Stocks to buy today: Lupin, Federal Bank among top 6 trading ideas

Economic Times

On the monthly options front, the maximum Call OI is placed at 19500 and then towards 19400 strikes while the maximum Put OI is placed at 19300 and then towards 19200 strikes.

Lupin Ltd.'s price crossed below 50Day SMA today

Lupin Ltd.

25 Aug 2023

1966.90

-3.09%

Lupin gets USFDA nod to market generic drug

Moneycontrol

The company has received approval from the US Food and Drug Administration (USFDA) to market Pirfenidone tablets in strengths of 267 mg and 801 mg, the Mumbai-based drug maker said in a statement.

Lupin Ltd. is trading below all available SMAs

Lupin Ltd.

24 Aug 2023

1966.90

-3.09%

LUPIN LIMITED

Hold: Lupin Ltd.

Target

Geojit BNP Paribas

Lupin Ltd.'s price crossed below 50Day SMA today

Lupin Ltd.

18 Aug 2023

1966.90

-3.09%

Lupin acquires two brands of diabetes medicines from Boehringer Ingelheim

Business Line

The transaction would include trademark rights associated with these brands, said Lupin, of its efforts to expand its diabetes portfolio

Lupin Ltd.'s price crossed below 50Day SMA today

Lupin acquires Ondero, Ondero Met from Germany's GmbH to expand diabetes portfolio

Moneycontrol | 18 Aug 2023

Lupin Ltd.

14 Aug 2023

1966.90

-3.09%

Lupin share price gains as USFDA concludes inspection without observations

Moneycontrol

The company had recorded a consolidated net profit of Rs 453.33 crore for the April-June quarter FY24, as against a consolidated net loss of Rs 86.8 crore reported in the same period a year ago.

Lupin Ltd. is trading below all available SMAs

Lupin Ltd.

09 Aug 2023

1966.90

-3.09%

Lupin gains after new drug approval from US FDA

Moneycontrol

The pharma major said that its New Jersey-based subsidiary Novel Laboratories has received approval from the US FDA for its abbreviated new drug application for fluocinolone acetonide oil.